Expanded Access Study for the Treatment of Patients With Commercially Out-of-Specification Brexucabtagene Autoleucel
Gilead Sciences
Gilead Sciences
Cogent Biosciences, Inc.
Autolus Limited
AbbVie
AbbVie
Phoenix Children's Hospital
Orca Biosystems, Inc.
Novartis
Novartis
Duke University
Syndax Pharmaceuticals
Institute of Hematology & Blood Diseases Hospital, China
Kura Oncology, Inc.
Children's Hospital of Philadelphia